Insilico Medicine Announces Industry’s First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery

B CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ — Insilico Medicine (“Insilico”, 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the strategic formation…
posteditor
posteditor
Articles: 17424

Other News